4//SEC Filing
Shrishrimal Sumi 4
Accession 0001093557-22-000055
CIK 0001093557other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:30 PM ET
Size
11.2 KB
Accession
0001093557-22-000055
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Shrishrimal Sumi
SVP Chief Risk Officer
Transactions
- Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−309$125,472→ 14,126 total - Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−192$77,963→ 14,435 total - Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−337$136,841→ 13,789 total - Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−519$210,743→ 14,627 total - Award
Common Stock
2022-03-08$0.00/sh+2,889$3→ 15,146 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001850687
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 7:30 PM ET
- Size
- 11.2 KB